According to Morgan Stanley’s China equity strategy report released in H2 2026, the firm raised its 2027 Q2 price targets for four major indices: Hang Seng Index to 28,400 points (implying 8% upside), MSCI China Index to 91 points (12% upside), Hang Seng China Enterprises Index to 9,900 points (11% upside), and CSI 300 Index to 5,400 points (11% upside). Morgan Stanley’s chief China equity strategist Wang Ying expects moderate gains driven by improving corporate earnings, strengthened Chinese dominance in global upstream supply chains, and yuan appreciation. The firm favors A-shares over offshore markets and recommends thematic stock selection over passive index investing.
Related News